Vilanterol trifenatate for the treatment of COPD-Reference-Cited by-同舟云学术

Vilanterol trifenatate for the treatment of COPD

Published:2016-05-25 Issue:7 Volume:10 Page:719-731
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Malerba Mario¹,Radaeli Alessandro²,Montuschi Paolo³,Morjaria Jaymin B.⁴

Affiliation:

1. Department of Internal Medicine, University of Brescia and ASST Spedali Civili, Brescia, Italy

2. Department of Emergency, ASST Spedali Civili, Brescia, Italy

3. Department of Pharmacology, Faculty of Medicine, University Hospital Agostino Gemelli, Catholic University of the Sacred Heart, Rome, Italy

4. Department of Respiratory Medicine, Royal Brompton & Harefield NHS Trust, Harefield Hospital, Middlesex, UK

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/17476348.2016.1184976

Reference67 articles.

1. From the global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2016 [cited 2016 Feb 20]. Available from: http://www.goldcopd.org/

2. Umeclidinium/vilanterol fixed-dose combination for COPD

3. Mono- and Combination Therapy of Long-Acting Bronchodilators and Inhaled Corticosteroids in Advanced COPD

4. Comparison of three combined pharmacological approaches with tiotropium monotherapy in stable moderate to severe COPD: A systematic review

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluticasone Furoate/Vilanterol Use Trends and Characteristics in Patients With Obstructive Airway Disease: A Real-World Study of 10,374 Patients From India;Cureus;2023-02-09

2. Chirality of β2-agonists. An overview of pharmacological activity, stereoselective analysis, and synthesis;Open Chemistry;2020-06-18

3. Fixed‐dose combination of umeclidinium and vilanterol for patients with chronic obstructive pulmonary disease: A systematic review;The Clinical Respiratory Journal;2019-09-02

Evidence-based review of data on the combination inhaler umeclidinium/vilanterol in patients with COPD

;International Journal of Chronic Obstructive Pulmonary Disease;2019-06

5. Single Inhaler LABA/LAMA for COPD;Frontiers in Pharmacology;2019-04-25